27.10.15

Guías NICE




Guías NICE de Agosto
Reference Guidance Programme Topic
IPG530 Transcranial direct current stimulation (tDCS) for depression

Interventional procedure guidance
Depression
IPG531 Preoperative high dose rate brachytherapy for rectal cancer

Interventional procedure guidance

Colorectal cancer

NG17

Type 1 diabetes in adults: diagnosis and management

Guideline

Diabetes
NG18
Diabetes (type 1 and type 2) in children and young people: diagnosis and management
Guideline
Diabetes


NG19

Diabetic foot problems: prevention and management

Guideline

Diabetes

TA352


Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy



Technology appraisal 
guidance


Inflammatory bowel disease


TA353


Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal)
Technology appraisal
Ovarian cancer
TA354

Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism



Technology appraisal guidance


Embolism and thrombosis

NG15

Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use

Guideline



Medicines management: general and other
Guías NICE de Septiembre
IPG532
Low energy contact X ray brachytherapy (the Papillon technique) for early stage rectal cancer

Interventional procedure guidance
Colorectal cancer
MTG27
Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C

Medical technology guidance
Chronic liver disease
TA355 Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

Technology appraisal guidance
Heart rhythm conditions
TA356
Ruxolitinib for treating polycythaemia vera (terminated
appraisal)

Technology appraisal
Blood conditions
NG21
Home care: delivering personal care and practical support to older people living in their own homes
Guideline
Carers
MTG26
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia

Medical technology guidance
Lower urinary tract symptoms

QS100
Cardiovascular risk assessment and lipid modification
Quality standard
Lipid disorders
QS99 Secondary prevention after a myocardial infarction
Quality standard
Acute coronary syndromes
IPG279 Autologous blood injection for tendinopathy
Interventional procedure guidance
IPG125 Posterior infracoccygeal sacropexy for vaginal vault prolapse

Interventional procedure guidance
NG20 Coeliac disease: recognition, assessment and management
Guideline
Coeliac disease
MT In development  HumiGard Surgical Humidification System for the prevention of inadvertent perioperative hypothermia

Medical technology guidance
Surgical care



1.10.15

"Habemus UpToDate"...¿pero sólo durante tres meses?


"El último contrato anual, formalizado el 8 de agosto de 2014, costó 2,7 millones de euros. El pasado 8 de septiembre la Secretaría General de Sanidad y Consumo adjudicó el suministro de licencia de suscripción a UpToDate, por un importe de 727.000 euros, según figura en la Plataforma de Contratación del Estado. En este caso, el plazo de ejecución es de tres meses."

Fuente: El Pais